These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4095734

  • 1. A proportional hazards analysis of bone sarcoma rates in German 224radium patients.
    Chmelevsky D, Kellerer AM, Spiess H, Mays CW.
    Strahlentherapie Sonderb; 1985; 80():32-7. PubMed ID: 4095734
    [No Abstract] [Full Text] [Related]

  • 2. Bone sarcoma cumulative tumor rates in patients injected with 224Ra.
    Mays CW, Spiess H, Chmelevsky D, Kellerer A.
    Strahlentherapie Sonderb; 1985; 80():27-31. PubMed ID: 4095733
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The reverse protraction factor in the induction of bone sarcomas in radium-224 patients.
    Chmelevsky D, Spiess H, Mays CW, Kellerer AM.
    Radiat Res; 1990 Oct; 124(1 Suppl):S69-79. PubMed ID: 2236514
    [Abstract] [Full Text] [Related]

  • 5. Bone tumors in thorotrast patients.
    Mays CW, Spiess H.
    Environ Res; 1979 Feb; 18(1):88-93. PubMed ID: 499146
    [No Abstract] [Full Text] [Related]

  • 6. [Late lesions following incorporation of 224Ra in animal experiment].
    Gössner W, Hindringer B, Hug O, Luz A, Müller WA.
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Feb; ():Suppl:149-50. PubMed ID: 4344543
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Malignancies in patients treated with high doses of radium-224.
    Nekolla EA, Kellerer AM, Kuse-Isingschulte M, Eder E, Spiess H.
    Radiat Res; 1999 Dec; 152(6 Suppl):S3-7. PubMed ID: 10564925
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathology of radium-induced bone tumors: new aspects of histopathology and histogenesis.
    Gössner W.
    Radiat Res; 1999 Dec; 152(6 Suppl):S12-5. PubMed ID: 10564927
    [Abstract] [Full Text] [Related]

  • 12. Dose-response relationships for radium-induced bone sarcomas.
    Rowland RE, Stehney AF, Lucas HF.
    Health Phys; 1983 Dec; 44 Suppl 1():15-31. PubMed ID: 6862895
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bone cancers induced by 224 Ra (Th X) in children and adults.
    Spiess H, Mays CW.
    Health Phys; 1970 Dec; 19(6):713-29. PubMed ID: 4935546
    [No Abstract] [Full Text] [Related]

  • 15. Induction of malignant bone tumors in radium-224 patients: risk estimates based on the improved dosimetry.
    Nekolla EA, Kreisheimer M, Kellerer AM, Kuse-Isingschulte M, Gössner W, Spiess H.
    Radiat Res; 2000 Jan; 153(1):93-103. PubMed ID: 10630982
    [Abstract] [Full Text] [Related]

  • 16. Dose and dose-rate dependence for bone sarcomas in radium-224 patients.
    Kellerer AM, Spiess H, Chmelevsky D.
    Int J Radiat Biol; 1990 Nov; 58(5):864-6. PubMed ID: 1977830
    [No Abstract] [Full Text] [Related]

  • 17. Comparing bone sarcoma induction in humans from 224Ra and 226+228Ra.
    Lloyd RD.
    Health Phys; 1993 Nov; 65(5):560-1. PubMed ID: 8225998
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The skeletal dose from 224Ra following intravascular administration of thorotrast.
    Rowland RE, Rundo J.
    RISO Rep; 1973 Jun; (294):95-103. PubMed ID: 4549676
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.